Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03662685 · ClinicalTrials.gov registry record · Phase 1
Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris
A Phase 1 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT03662685 is a Phase 1 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 4 participants.
The verdict
NCT03662685, a Phase 1 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study examines the effect of Goeckerman therapy (a combination of phototherapy and topical crude coal tar), crude coal tar alone, and phototherapy alone on the immunologic and genetic environment within psoriatic skin lesions.
Interventions
- OTHER Goeckerman Therapy
- DRUG Crude Coal Tar Only
- DEVICE Phototherapy Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2024-05-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03662685
The ClinicalTrials.gov registry entry for NCT03662685 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Goeckerman Therapy is the first listed.
NCT03662685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03662685 about?
NCT03662685 is a clinical study titled "Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris". This study examines the effect of Goeckerman therapy (a combination of phototherapy and topical crude coal tar), crude coal tar alone, and phototherapy alone on the immunologic and genetic environment within psoriatic skin lesions.
What is the current status of trial NCT03662685?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2018-08-01. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT03662685?
The interventions under investigation include: Goeckerman Therapy (OTHER), Crude Coal Tar Only (DRUG), Phototherapy Only (DEVICE).
Who is sponsoring clinical trial NCT03662685?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.